“third-rock-ventures” Archives

in
Entry Author Date Location
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Neon Therapeutics Garners $70,000,000 Series B Round 01/06/17 Boston
Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs 01/05/17 Boston
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines 01/05/17 Boston
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
REVOLUTION Medicines Garners $25,000,000 Series A Funding 12/22/16 San Francisco
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
Goldfinch Bio Obtains $55,000,000 Series A Round 12/15/16 Boston
Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease 12/14/16 Boston
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Magenta Therapeutics Lands $48,500,000 Series A Financing 11/17/16 Boston
Harvard Spinout Magenta, Other Academics Race Toward Better Stem Cell Transplants 11/16/16 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Relay Therapeutics Garners $57,000,000 Series A Funding Round 09/15/16 Boston
New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion 09/14/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Fulcrum Therapeutics Garners $55,000,000 Series A Funding 07/21/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup 06/30/16 Boston
See Boston’s Newest Innovators & Influencers this Wed. at INFLUX 06/20/16 Boston
A Few Tickets Still Remain for Influx—Register Today for June 22 06/13/16 Boston
Five Takeaways from “What’s Hot in Boston Biotech” 04/11/16 Boston
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy 03/15/16 Boston
East Coast Biotech Roundup: Celldex, Ensemble, CRISPR Battle & More 03/10/16 Boston
Page 1 of 15 next page »